Review article: Cytomegalovirus and inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 8, 2015, Pages 725-733

  Sager, K ^a   Alam, S ^a   Bond, A ^a   Chinnappan, L ^a   Probert, C S ^a,b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; INFLIXIMAB; STEROID; VALGANCICLOVIR; ANTIVIRUS AGENT;

ANEMIA; ANTIVIRAL THERAPY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COLON RESECTION; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPY; HEADACHE; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; MONOCYTE; NAUSEA; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RASH; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; STAINING; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; ULCERATIVE COLITIS; VIRUS REACTIVATION; VOMITING; BIOPSY; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ANTIVIRAL AGENTS; BIOPSY; COLECTOMY; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; MONOCYTES; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STEROIDS;

EID: 84925105609     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13124     Document Type: Article

References (51)

1. Lockwood MR, Liddle J, Kitsanta P,. Cytomegalovirus colitis-an unusual cause for diarrhoea in an elderly woman. Age Ageing 2006; 35: 198-200.
2. Banerjee D, Deb R, Dar L, et al,. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scand J Gastroenterol 2009; 44: 325-31.
3. Dieterich DT, Rahmin M,. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991; 4 (Suppl. 1): S29-35.
4. Yoshikawa T,. Significance of human herpesviruses to transplant recipients. Curr Opin Infect Dis 2003; 16: 601-6.
5. Ogunneye O, Hernandez J,. Acute cytomegalovirus colitis mimicking exacerbation of ulcerative colitis: precipitating or coincidental? Am J Med 2012; 125: e3-4.
6. Powell RD, Warner NE, Levine RS, Kirsner JB,. Cytomegalic inclusion disease and ulcerative colitis: report of a case in a young adult. Am J Med 1961; 30: 334-40.
7. Domenech E, Vega R, Ojanguren I, et al,. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008; 14: 1373-9.
8. Yi F, Zhao J, Luckheeram RV, et al,. The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virol J 2013; 10: 43.
9. Roblin X, Pillet S, Oussalah A, et al,. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011; 106: 2001-8.
10. Iida T, Ikeya K, Watanabe F, et al,. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus. Inflamm Bowel Dis 2013; 19: 1156-63.
11. Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A,. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 879-84.
12. Christidou A, Zambeli E, Mantzaris G,. Cytomegalovirus and inflammatory bowel disease: pathogenicity, diagnosis and treatment. Ann Gastroenterol 2007; 20: 110-5.
13. Maher MM, Nassar MI,. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci 2009; 54: 2456-62.
14. Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K,. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010; 16: 1245-51.
15. Omiya M, Matsushita M, Tanaka T, Kawamata S, Okazaki K,. The absence of large ulcer predicts latent cytomegalovirus infection in ulcerative colitis with positive mucosal viral assay. Intern Med 2010; 49: 2277-82.
16. Garrido E, Carrera E, Manzano R, Lopez-Sanroman A,. Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol 2013; 19: 17-25.
17. Leveque N, Brixi-Benmansour H, Reig T, et al,. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. J Med Virol 2010; 82: 1694-700.
18. Kandiel A, Lashner B,. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006; 101: 2857-65.
19. Beaugerie L, Cywiner-Golenzer C, Monfort L, et al,. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 423-9.
20. McCoy MH, Post K, Sen JD, et al,. qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies. Hum Pathol 2014; 45: 48-53.
21. Cotte L, Drouet E, Bissuel F, Denoyel GA, Trepo C,. Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol 1993; 31: 2066-9.
22. Rahier JF, Ben-Horin S, Chowers Y, et al,. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009; 3: 47-91.
23. Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J,. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004; 10: 245-50.
24. Nakase H, Yoshino T, Honzawa Y, Chiba T,. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci 2010; 55: 1498-9.
25. Knosel T, Schewe C, Petersen N, Dietel M, Petersen I,. Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract 2009; 205: 223-30.
26. Takahashi Y, Tange T,. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum 2004; 47: 722-6.
27. Kojima T, Watanabe T, Hata K, Shinozaki M, Yokoyama T, Nagawa H,. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol 2006; 41: 706-11.
28. Kuwabara A, Okamoto H, Suda T, Ajioka Y, Hatakeyama K,. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2007; 42: 823-9.
29. Kambham N, Vij R, Cartwright CA, Longacre T,. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004; 28: 365-73.
30. Matsuoka K, Iwao Y, Mori T, et al,. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007; 102: 331-7.
31. Delvincourt M, Lopez A, Pillet S, et al,. The impact of cytomegalovirus reacti-vation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther 2014; 39: 712-20.
32. Al-Zafiri R, Gologan A, Galiatsatos P, Szilagyi A,. Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (NY) 2012; 8: 230-9.
33. Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR,. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998; 177: 1182-7.
34. Kishore J, Ghoshal U, Ghoshal UC, et al,. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004; 53: 1155-60.
35. Pillet S, Pozzetto B, Jarlot C, Paul S, Roblin X,. Management of cytomegalovirus infection in inflammatory bowel diseases. Dig Liver Dis 2012; 44: 541-8.
36. D'Ovidio V, Vernia P, Gentile G, et al,. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008; 43: 180-3.
37. Cottone M, Pietrosi G, Martorana G, et al,. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96: 773-5.
38. Criscuoli V, Casa A, Orlando A, et al,. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36: 818-20.
39. Papadakis KA, Tung JK, Binder SW, et al,. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 2137-42.
40. Vega R, Bertran X, Menacho M, et al,. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1053-6.
41. Hashash JG, Refaat M, Abdulbaki A, Aoun EG, Baidoo L,. Cytomegalovirus colitis. Clevel Clin J Med 2012; 79: 12-3.
42. Goodgame RW,. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119: 924-35.
43. Drew WL, Paya CV, Emery V,. Cytomegalovirus (CMV) resistance to antivirals. Am J Transplant 2001; 1: 307-12.
44. Emery VC,. Progress in understanding cytomegalovirus drug resistance. J Clin Virol 2001; 21: 223-8.
45. Lurain NS, Bhorade SM, Pursell KJ, et al,. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis 2002; 186: 760-8.
46. Griffiths PD,. Cytomegalovirus therapy: current constraints and future opportunities. Curr Opin Infect Dis 2001; 14: 765-8.
47. Khare MD, Sharland M,. Cytomegalovirus treatment options in immunocompromised patients. Expert Opin Pharmacother 2001; 2: 1247-57.
48. de la Hoz RE, Stephens G, Sherlock C,. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002; 25 (Suppl. 2): S1-12.
49. Kim YS, Kim YH, Kim JS, et al,. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol 2012; 46: 51-6.
50. Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L,. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010; 55: 1059-65.
51. Kim YS, Kim YH, Kim JS, et al,. Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study. Hepatogastroenterology 2012; 59: 1098-101.